René Russo
Directeur Général chez XILIO THERAPEUTICS, INC.
Fortune : 202 639 $ au 30/04/2024
Postes actifs de René Russo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XILIO THERAPEUTICS, INC. | President | 08/09/2023 | - |
| Directeur Général | 22/05/2019 | - | |
| Directeur/Membre du Conseil | 22/05/2019 | 08/09/2023 | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/05/2020 | - |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Directeur Général | - | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - | - |
| Life Science Cares, Inc. | Directeur/Membre du Conseil | - | - |
Leyden Labs
 Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Directeur/Membre du Conseil | - | - |
Historique de carrière de René Russo
Anciens postes connus de René Russo
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INVIVYD, INC. | Président | 03/06/2020 | 01/07/2022 |
| Fondateur | 03/06/2020 | 01/07/2022 | |
| Independent Dir/Board Member | 03/06/2020 | 01/07/2022 | |
| INVIVYD, INC. | Président | 01/07/2020 | 01/06/2022 |
| X4 PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2016 | 11/11/2021 |
| Directeur Général | 01/04/2016 | 26/11/2018 | |
| Corporate Officer/Principal | 01/07/2015 | 01/04/2016 | |
| President | 01/04/2016 | 26/11/2018 | |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de René Russo
| Rutgers Business School | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 11 |
| Pays-Bas | 2 |
Opérationnelle
| Director/Board Member | 6 |
| Chief Executive Officer | 4 |
| President | 3 |
Sectorielle
| Health Technology | 9 |
| Consumer Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Life Science Cares, Inc. | |
Leyden Labs
Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Health Technology |
- Bourse
- Insiders
- René Russo
- Expérience